BioLife Solutions, Inc.

BLFS

$21.54

Name : BioLife Solutions, Inc.

Sector : Healthcare

Industry: Medical Instruments & Supplies

Mark. Cap: $1,037,108,992.00

EPSttm : -0.38

BioLife Solutions, Inc.

$21.54

3.19%

$0.71

Float Short %

6.29

Margin Of Safety %

-18

Put/Call OI Ratio

0.03

EPS Next Q Diff

-0.03

EPS Last/This Y

0.52

EPS This/Next Y

0.08

Price

22.25

Target Price

32.44

Analyst Recom

Performance Q

-15.37

Relative Volume

0.61

Beta

1.92

Ticker: BLFS

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-01-13	BLFS	23.87	0.21	0.00	239
2026-01-14	BLFS	24.29	N/A	N/A	0
2026-01-15	BLFS	24.46	0.21	0.00	241
2026-01-16	BLFS	24.41	0.20	0.00	242
2026-01-20	BLFS	24.75	0.04	0.00	139
2026-01-21	BLFS	25.55	0.03	0.00	153
2026-01-22	BLFS	25.93	0.03	0.00	153
2026-01-23	BLFS	24.88	0.03	0.00	153
2026-01-26	BLFS	24.94	0.03	999.99	154
2026-01-27	BLFS	25	0.03	999.99	154
2026-01-28	BLFS	22.96	0.03	999.99	154
2026-01-29	BLFS	22.59	0.03	0.00	154
2026-01-30	BLFS	21.83	0.03	0.00	154
2026-02-02	BLFS	22.37	0.03	0.00	154
2026-02-03	BLFS	22.78	0.03	0.00	154
2026-02-05	BLFS	22.03	0.03	0.00	157
2026-02-09	BLFS	22.7	0.03	0.00	157
2026-02-10	BLFS	22.69	0.03	0.00	157
2026-02-11	BLFS	22.25	0.03	0.00	157
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-01-13	BLFS	23.90	131.3	-	0.08
2026-01-14	BLFS	24.28	131.3	-	0.08
2026-01-15	BLFS	24.47	131.3	-	0.08
2026-01-16	BLFS	24.44	131.3	-	0.08
2026-01-20	BLFS	24.75	131.3	-	0.08
2026-01-21	BLFS	25.57	131.3	-	0.08
2026-01-22	BLFS	25.99	131.3	-	0.08
2026-01-23	BLFS	24.87	131.3	-	0.08
2026-01-26	BLFS	24.91	131.3	-	0.08
2026-01-27	BLFS	24.98	131.3	-	0.08
2026-01-28	BLFS	22.97	131.3	-	0.08
2026-01-29	BLFS	22.58	131.3	-	0.08
2026-01-30	BLFS	21.81	131.3	-	0.08
2026-02-02	BLFS	22.33	131.3	-	0.08
2026-02-03	BLFS	22.85	131.3	-	0.08
2026-02-04	BLFS	22.66	131.3	-	0.08
2026-02-05	BLFS	22.06	131.3	-	0.08
2026-02-06	BLFS	22.45	131.3	-	0.08
2026-02-09	BLFS	22.66	131.3	-	0.08
2026-02-10	BLFS	22.66	131.3	-	0.08
2026-02-11	BLFS	22.25	131.3	-	0.08
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-01-13	BLFS	-53.40	1.17	6.44
2026-01-14	BLFS	-53.40	1.17	6.44
2026-01-15	BLFS	-53.40	1.17	6.44
2026-01-16	BLFS	-53.40	1.17	6.44
2026-01-20	BLFS	-53.40	1.00	6.44
2026-01-21	BLFS	-53.40	1.00	6.44
2026-01-22	BLFS	-53.40	1.00	6.44
2026-01-23	BLFS	-53.39	1.00	6.44
2026-01-26	BLFS	-53.39	1.52	6.44
2026-01-27	BLFS	-53.39	1.52	6.44
2026-01-28	BLFS	-53.39	1.52	6.10
2026-01-29	BLFS	-53.39	1.52	6.10
2026-01-30	BLFS	-53.39	1.52	6.10
2026-02-02	BLFS	-53.39	1.53	6.10
2026-02-03	BLFS	-53.39	1.53	6.10
2026-02-04	BLFS	-53.39	1.53	6.10
2026-02-05	BLFS	-53.39	1.53	6.10
2026-02-06	BLFS	-53.39	1.53	6.10
2026-02-09	BLFS	-53.39	1.43	6.10
2026-02-10	BLFS	-53.39	1.43	6.10
2026-02-11	BLFS	-53.39	1.43	6.29
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

0.04

Avg. EPS Est. Current Quarter

0.01

Avg. EPS Est. Next Quarter

0.01

Insider Transactions

-53.39

Institutional Transactions

1.43

Beta

1.92

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

18.14

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

63.3

Max Drawdown 5-Year %

-85.1

Target Price

32.44

P/E

Forward P/E

222.3

PEG

P/S

10.7

P/B

3.02

P/Free Cash Flow

98.65

EPS

-0.07

Average EPS Est. Cur. Y

0.08

EPS Next Y. (Est.)

0.16

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-3.2

Relative Volume

0.61

Return on Equity vs Sector %

-28.8

Return on Equity vs Industry %

-11.5

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.08

EBIT Estimation

BioLife Solutions, Inc.

Sector: Healthcare

Industry: Medical Instruments & Supplies

Employees: 159

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line include automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

stock quote shares BLFS – BioLife Solutions, Inc. Stock Price stock today

news today BLFS – BioLife Solutions, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch BLFS – BioLife Solutions, Inc. yahoo finance google finance

stock history BLFS – BioLife Solutions, Inc. invest stock market

stock prices BLFS premarket after hours

ticker BLFS fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: BLFS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y